Laquinimod May Be Effective for the Long-Term Management of Multiple SclerosisJuly 1, 2012Multiple Sclerosis
Data Are Unclear About the Effectiveness of Laquinimod in Multiple Sclerosis—by Stuart Cook, MDJuly 1, 2012Multiple Sclerosis
Tool Allows MS Patients to Assess How Their Impairment Compares to That of Other Patients With Same Disease DurationJuly 1, 2012Multiple Sclerosis
Combined Use of Interferon beta-1a and Glatiramer Acetate May Not Be Superior to Glatiramer Acetate Alone in Reducing MS RelapsesJuly 1, 2012Multiple Sclerosis
The CombiRx Trial Could Shed Light on the MS Disease Process—by Richard A. Rudick, MDJuly 1, 2012Multiple Sclerosis
Alemtuzumab Will Help Clinicians Treat Patients With MS More Effectively—By Mark Gudesblatt, MDJune 1, 2012Multiple Sclerosis
Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II StudyJune 1, 2012Multiple Sclerosis
Alemtuzumab May Provide Greater Benefit Than Interferon Beta-1a for Treatment-Naïve Patients With MS—Results From the CARE-MS I StudyJune 1, 2012Multiple Sclerosis
New and Noteworthy Information—MayMay 1, 2012Alzheimer's & CognitionEpilepsy & SeizuresMultiple SclerosisMovement DisordersParkinson's Disease
New and Noteworthy InformationApril 1, 2012Alzheimer's & CognitionMultiple SclerosisMovement DisordersParkinson's Disease
Comorbid Migraine and Multiple Sclerosis Can Pose Challenges for NeurologistsApril 1, 2012Headache & MigraineMultiple Sclerosis
